Since its founding, the AMN has:

  • Created a unified database to assess the incidence of myeloma in Asian countries as a basis for establishing region-specific treatment management tools and strategies
  • Launched and overseen clinical trials
  • Enabled myeloma patients to gain access to the newest myeloma treatments
  • Developed informational resource materials in local languages, especially for patients and care givers
  • Engaged in collaborative studies